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dult neurogenesis is studied in vivo using thy-
midine analogues such as bromodeoxyuridine
(BrdU) to label DNA synthesis during the S
phase of the cell cycle. However, BrdU may also label
DNA synthesis events not directly related to cell prolifera-
tion, such as DNA repair and/or abortive reentry into the
cell cycle, which can occur as part of an apoptotic pro-
cess in postmitotic neurons. In this study, we used three
well-characterized models of injury-induced neuronal
apoptosis and the combined visualization of cell birth
(BrdU labeling) and death (Tdt-mediated dUTP-biotin nick
A
 
end labeling) to investigate the speciﬁcity of BrdU incor-
poration in the adult mouse brain in vivo. We present
evidence that BrdU is not signiﬁcantly incorporated dur-
ing DNA repair and that labeling is not detected in vul-
nerable or dying postmitotic neurons, even when a high
dose of BrdU is directly infused into the brain. These
ﬁndings have important implications for a controversy
surrounding adult neurogenesis: the connection between
cell cycle reactivation and apoptosis of terminally differ-
entiated neurons.
 
Introduction
 
The adult mammalian brain contains neural stem/progenitor
cells that proliferate and generate new neurons and glia, both in
vitro and in vivo (Gage, 2000; Doetsch, 2003). Although neural
stem cells reside in various areas of the nervous system
(Taupin and Gage, 2002), adult neurogenesis has been unam-
biguously demonstrated in vivo in only two well-defined re-
gions, the olfactory bulb and the hippocampus, in rodents and
primates, including humans (Peterson, 2002).
The study of adult neurogenesis is limited by currently
available techniques for identifying newly generated cells. In
vivo, thymidine analogues such as tritiated thymidine or BrdU,
which are incorporated into nuclear DNA during the S phase of
the cell cycle, are often used to label proliferating cells (Rakic,
2002a). BrdU is very useful because it is revealed by immuno-
histochemistry, which can be combined with cell type–specific
markers and confocal microscopy to identify the phenotypes of
newly generated cells.
However, BrdU may also be incorporated during DNA
synthesis not related to cell proliferation, such as normal DNA
turnover or DNA repair (Nowakowski and Hayes, 2000; Cooper-
Kuhn and Kuhn, 2002; Rakic, 2002a,b). In addition, a growing
number of studies show that terminally differentiated neurons
can reenter the cell cycle and incorporate BrdU as part of an
apoptotic process (Copani et al., 2001; Becker and Bonni,
2004; Greene et al., 2004; Herrup et al., 2004), which is appar-
ently triggered by the DNA damage response (Kruman et al.,
2004). For instance, key regulators of the cell cycle, such as cy-
clins and Cdks, are up-regulated in postmitotic neurons sub-
jected to a variety of death-inducing stimuli in vitro or in vivo,
as well as in Alzheimer’s disease (AD; Greene et al., 2004),
where vulnerable neurons could initiate abortive DNA synthe-
sis without cell division before undergoing cell death (Yang et
al., 2001). Preventing the induction of cyclin D1 or Cdk4 pro-
tects against excitotoxin-induced neuronal death in vivo in the
adult rat, demonstrating the direct involvement of cell cycle
regulators in the death of terminally differentiated neurons
(Ino and Chiba, 2001).
Such findings raise the question of whether BrdU could
be incorporated in vivo into dying postmitotic neurons and
ultimately lead to false positive staining when studying neu-
rogenesis (Rakic, 2002a). Clarification is needed because
these uncertainties undermine the discovery of new areas in
the adult brain, including the septum, hypothalamus, striatum
(Pencea et al., 2001), amygdala (Bernier et al., 2002), and
dorsal vagal complex (Bauer et al., 2005), where ongoing neu-
rogenesis may occur at low levels and requires a higher dose of
BrdU and/or repeated injections to be visualized. More contro-
versial still are the substantia nigra (Kay and Blum, 2000; Lie
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et al., 2002; Zhao et al., 2003; Frielingsdorf et al., 2004) and
frontal cortex (Gould et al., 2001; Kornack and Rakic, 2001;
Koketsu et al., 2003). In the present study, we used BrdU/
TUNEL double labeling in established models of injury-induced
neuronal cell death to examine the possibility that BrdU labels
dying postmitotic neurons in vivo in the adult mouse brain. To
obtain the highest level of sensitivity, we used repeated injec-
tions or direct infusion of a high dose of BrdU into the brain.
 
Results
 
Olfactory bulbectomy (OBX)
 
We took advantage of the unilateral OBX model (Michel et
al., 1994; Holcomb et al., 1995; Bauer et al., 2003) to estab-
lish BrdU/TUNEL double-labeling methods. Because neuronal
apoptosis occurs only in the olfactory epithelium (OE) ipsilateral
to the lesion, this model provides both internal negative and pos-
itive controls for the TUNEL reaction (Fig. 1 A). In addition, on-
going proliferation of neuronal progenitors in the basal cell layer
of the OE (Schwartz Levey et al., 1991) ensures consistent BrdU
incorporation in this tissue. After OBX, animals were killed at
the peak of injury-induced apoptosis (36–48 h; Michel et al.,
1994; Holcomb et al., 1995), receiving i.p. BrdU injections once
2 h before sacrifice (100 or 300 mg/kg) or 10 times (100 mg/kg)
during the 24-h period preceding sacrifice.
Ipsilateral to the lesion, TUNEL
 
 
 
 nuclei are located in
the middle of the OE (Fig. 1, A, E, and F). They correspond to
dying olfactory sensory neurons (Holcomb et al., 1995) whose
axons, in the lamina propria beneath the OE, express high lev-
els of activated caspase 3 (casp-3; Fig. 1 B; Cowan et al.,
2001). In animals receiving a single BrdU injection, only a
few scattered BrdU
 
 
 
 nuclei are found next to the basal lamina
(Fig. 1 C), where proliferating cells are normally located
(Schwartz Levey et al., 1991). Considerably more labeled nu-
clei, extending toward the surface of the OE, are detected
when BrdU is given in repeated injections (Fig. 1 D). In such
animals, observation of double labeling under epifluorescent
light reveals virtually no colocalization with TUNEL staining
(Fig. 1, E and F).
The occurrence of double-labeled cells was carefully
investigated using three-dimensional laser confocal micros-
copy. Despite cases of close apposition between BrdU
 
 
 
 and
TUNEL
 
 
 
 nuclei, no colocalization was detected in animals re-
ceiving a single BrdU injection at either dose used (unpub-
lished data). In contrast, in animals subjected to multiple BrdU
injections, a few nuclei (up to 25 per section) are simulta-
neously labeled with BrdU and TUNEL (Fig. 2). In most cases,
double-stained nuclei are located in the basal OE next to the
lamina propria (Fig. 2, C–E); some also colocalize with TuJ1, a
marker of immature neurons (Fig. 2 C).
These results show that BrdU is only marginally detected
in dying olfactory sensory neurons after OBX: although exten-
sive TUNEL staining is observed in the OE (
 
 
 
2,500 TUNEL
 
 
 
nuclei per section), 
 
 
 
1% of the TUNEL
 
 
 
 nuclei are simulta-
neously labeled with BrdU. Moreover, double-stained nuclei
are exclusively found in animals subjected to multiple injec-
tions of BrdU and generally reside in the basal OE, where pro-
liferation normally occurs. These observations suggest that
BrdU is incorporated in proliferating neuronal precursors be-
fore they undergo apoptosis, rather than during the apoptotic
Figure 1. Validation of the BrdU/TUNEL double staining in the adult
mouse OE 36–48 h after unilateral right OBX. (A) Unilateral OBX leads to
massive apoptosis of olfactory sensory neurons in the ipsilateral OE only,
visualized by TUNEL staining (red). The basal lamina (dashed line) sepa-
rates the OE proper (arrow) from underlying lamina propria (arrowhead).
Bar, 200  m. (B) The lamina propria contains axon bundles of olfactory
sensory neurons, expressing high levels of casp-3 (green). Bar, 200  m.
(C) After a single BrdU injection, the OE contains only a few scattered
BrdU
  nuclei next to the basal lamina (green). Bar, 200  m. (D) Repeated
injections of BrdU over a 24-h period leads to many more BrdU
  nuclei,
extending toward the surface of the OE. Bar, 200  m. (E and F) Combina-
tion of BrdU staining (green) and TUNEL labeling (red) in the OE of the lat-
ter animal visualized under epifluorescence indicates that colocalization is
very rare. Bars, 50  m. 
Figure 2. 2 d after unilateral OBX, the OE contains many dying neurons
but rare BrdU/TUNEL colocalization, detected only when BrdU is given
repeatedly. (A) TUNEL staining (red) colocalizes with BrdU (green) in vari-
ous patterns with considerable overlap. (B) BrdU staining is shown inside
a TUNEL
  nucleus. (C) TUNEL staining is shown inside a BrdU
  nucleus.
(A and B) Vertical images show orthogonal projections along the z axis.
(C–E) Colocalization is most often detected in the basal OE, where progen-
itor cells proliferate and immature neurons (TuJ1 in blue) are generated.
Bars: (A) 5  m; (B) 10  m; (C) 50  m; (D and E) 20  m. 
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process. This conclusion is supported by extensive colocaliza-
tion between BrdU and TuJ1 (Fig. 2), as well as by the known
susceptibility of these immature neurons to OBX-induced
apoptosis (Holcomb et al., 1995).
 
Brain irradiation
 
To investigate the possibility that DNA repair is a source of
BrdU incorporation not related to cell proliferation, we sub-
jected an adult mouse to brain irradiation, followed by an i.p.
injection of 100 mg/kg BrdU at 4, 5, 6, 7, and 8 h after irradia-
tion and killing at 8.5 h (30 min after the last BrdU injection).
In a nonirradiated animal receiving the same regimen of
BrdU injection, BrdU labeling is found almost exclusively in
areas of ongoing proliferation, i.e., the subventricular zone
(SVZ) of the lateral ventricle and the subgranular zone (SGZ)
of the hippocampus (Fig. 3). Only scarce TUNEL
 
 
 
 nuclei are
detected in either germinal zone (Fig. 3 and Table I). Interest-
ingly, the noninjured SVZ, but not the SGZ, contains TUNEL
 
 
 
nuclei colabeled with BrdU (7.8 
 
 
 
 3.6% of the total TUNEL
 
 
 
nuclei; Fig. 3 B and Table I). This contrasts with the case of a
single BrdU injection where no BrdU/TUNEL colabeling is de-
tected (Cooper-Kuhn and Kuhn, 2002) and could be attribut-
able to the potential toxicity of the drug when administered in
repeated injections.
Brain irradiation induces extensive TUNEL labeling,
which is also largely restricted to areas of ongoing prolifera-
tion (Fig. 3). At the same time, both the SVZ and SGZ display
a more than twofold reduction in the number of BrdU
 
 
 
 nuclei
(Fig. 3 and Table I). Irradiation of the rodent adult brain has
been shown to preferentially kill proliferating cells (Peissner
et al., 1999). Outside these two germinal zones, only a few
nuclei are either BrdU
 
 
 
 or TUNEL
 
 
 
, and double labeling is
very rare (unpublished data). In addition, we never found
BrdU staining in postmitotic NeuN
 
 
 
 neurons in any brain
region examined (unpublished data). In the SVZ or SGZ,
 
 
 
73% of the BrdU
 
 
 
 nuclei colocalize with TUNEL staining
(Fig. 3 and Table I), reflecting the death of proliferating cells,
as well as putative BrdU incorporation attributable to DNA
repair/apoptosis. However, a great majority of the dying cells
does not incorporate BrdU because only 22.5 
 
 
 
 1.6% and
12.8 
 
 
 
 2.3% of the TUNEL
 
 
 
 nuclei are simultaneously la-
beled with BrdU in the SVZ and SGZ, respectively (Fig. 3
and Table I). Interestingly, both regions also display some
double-stained nuclei that express the proliferation marker
Ki67 (Fig. 3, E and F), confirming that a few BrdU/TUNEL–
positive cells are proliferating.
Despite this apparent increase in BrdU/TUNEL colocal-
ization induced by brain irradiation, it is not possible to clearly
Figure 3. Detection of BrdU and TUNEL stain-
ing 8.5 h after brain irradiation shows a large
increase in neuronal death but a decrease in
BrdU incorporation. Brain irradiation (IR) in-
duces a  44-fold increase in TUNEL
  nuclei
in the SVZ of the lateral ventricle (A, dotted
line) and the SGZ of the hippocampus (C, dot-
ted line). In the control brain (CC), sporadic
cell death is detected (arrows). After brain ir-
radiation, BrdU incorporation is reduced more
than twofold in both germinal zones (compare
B and D with A and C, respectively) and vir-
tually all BrdU
  nuclei are simultaneously
TUNEL
  (A’–A’’’ and insets in C, correspond-
ing to areas marked by asterisks in A and C,
respectively). (B’ and B”) BrdU/TUNEL colo-
calization is also found in the normal adult
brain but to a considerably lesser extent and
only in the SVZ. (B”) Vertical image shows or-
thogonal projection along the z axis. (E and F)
After brain irradiation, some of the BrdU/
TUNEL double-stained nuclei are also positive
for Ki67 (blue), indicating cellular proliferation.
Bars: (A–D) 50  m; (A’–B”) 20  m; (C, insets)
30  m; (E and F) 10  m.
 
Table I. 
 
Mean number of positive cells (
 
 
 
 SEM) for TUNEL, BrdU, or double-labeled BrdU
 
 
 
/TUNEL
 
 
 
 quantified in the control brain and 8.5 h after 
brain irradiation in the SVZ and the hippocampal SGZ
Brain irradiation Control brain
Staining SVZ SGZ SVZ SGZ
 
BrdU 85.5 
 
 
 
 2.58 15 
 
 
 
 2.62 207.33 
 
 
 
 6.24 33.17 
 
 
 
 1.3
TUNEL 283 
 
 
 
 13.63 93.33 
 
 
 
 9.13 6.33 
 
 
 
 1.15 0.5 
 
 
 
 0.34
Double
Among TUNEL
62.5 
 
 
 
 2.48
(22.52 
 
 
 
 1.64)
 
a
 
11.67 
 
 
 
 1.94
(12.84 
 
 
 
 2.33)
 
a
 
0.67 
 
 
 
 0.33
(7.80 
 
 
 
 3.63)
 
a
 
0
(0)
 
a
 
a
 
Parentheses indicate the ratio of double-labeled cells among the total number of TUNEL
 
 
 
 cells. 
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identify the source of BrdU incorporation because it could oc-
cur before cell death during cell proliferation or during DNA
repair/apoptosis. In an attempt to differentiate between these
two possibilities, we used a double-nucleoside labeling strat-
egy by injecting two thymidine analogues, iododeoxyuridine
(IdU) and chlorodeoxyuridine (CldU), before and after brain
irradiation, respectively. In this paradigm, IdU
 
 
 
 cells are in-
dicative of nucleoside incorporation that relates to cell prolif-
eration before induction of DNA repair, whereas CldU
 
 
 
 cells
indicate nucleoside incorporation that relates to both cell pro-
liferation and DNA repair/apoptosis. If a significant amount of
nucleoside is incorporated during DNA repair, then an in-
creased CldU incorporation (cell proliferation plus DNA re-
pair) should be detected, compared with IdU incorporation
(cell proliferation only).
Brain irradiation was performed in one animal that re-
ceived a single IdU injection 1.5 h before initiating irradia-
tion, followed by a single CldU injection 6 h after irradiation
and 2 h before perfusion. By comparing the effects of this
procedure with those on a control animal that received the
same injection paradigm, we discovered that brain irradia-
tion reduces the number of IdU
 
 
 
 and CldU
 
 
 
 nuclei by 41
and 75%, respectively (Fig. 4 and Table II), confirming that
irradiation kills proliferating cells (IdU
 
 
 
) and reduces cell
proliferation (CldU
 
 
 
). Given that IdU and CldU injections
were separated by 8 h, that the bioavailability of IdU and
CldU may be similar to BrdU (at least 2 h; Takahashi et al.,
1992), and that the cell cycle for SVZ cells has been esti-
mated to last 
 
 
 
12.7 h with an S phase of 
 
 
 
4.2 h (Morshead
and van der Kooy, 1992), IdU/CldU double-stained cells
represent cells that are still in the S phase (labeled during the
same cell cycle), as well as CldU-incorporating, proliferat-
ing daughter cells of a progenitor that had incorporated IdU
in the previous cell cycle. Brain irradiation reduces the num-
ber of IdU/CldU double-stained nuclei by 52%, which is
slightly more than the reduction of IdU
 
 
 
 cells alone (41%;
indicating death of proliferating cells), suggesting that irra-
diation also prevents progenitors from reentering the cell cy-
cle. Interestingly, although 
 
 
 
50% of the CldU
 
 
 
 nuclei are
also IdU
 
 
 
 in the control animal, virtually all (91%) of the
CldU
 
 
 
 nuclei colocalize with IdU after irradiation (Table II).
This indicates that most of the cells labeled with CldU after
irradiation were in the S phase of the cell cycle before irradi-
ation, which could represent cells that either terminate their
S phase or exit the S phase and incorporate CldU during
DNA repair. The latter should therefore lead to an increased
CldU staining in IdU
 
 
 
 cells compared with the control ani-
mal. However, the proportion of CldU
 
 
 
 nuclei among IdU
 
 
 
cells is slightly reduced after irradiation (28%) versus con-
trol (35%), indicating that DNA repair/apoptosis does not
trigger an increased CldU incorporation in cells that were
proliferating in healthy condition. This lack of increased
Figure 4. Detection of IdU and CldU staining
8 h after brain irradiation indicates a reduc-
tion in both labels. IdU (green) was injected
1.5 h before irradiation, whereas CldU (red)
was injected 6 h after irradiation. (A and B)
Brain irradiation (IR) decreases IdU
  and
CldU
  nuclei by 40 and 75%, respectively, in
the SVZ of the lateral ventricle (dotted lines)
compared with control (CC). Insets in B corre-
spond to high-power magnification pictures
showing single IdU
  or CldU
  cells, as well as
double-stained cells in the control SVZ (B’ and
B”, arrows). After brain irradiation, most of
the CldU
  nuclei are also labeled with IdU
(A’–A’’’, corresponding to areas marked by
asterisks in A). (C) Brain irradiation induces
strong expression of casp-3 (green) in the
SVZ, as well as massive TUNEL staining (red).
Interestingly, when BrdU is injected repeatedly
after brain irradiation, most of the BrdU stain-
ing (blue) is found in TUNEL
  cells and only
in a few caspase 3
  cells (arrows). Bars: (A
and B) 50  m; (A’–B” and C) 10  m.
 
Table II. 
 
Mean number of positive cells (
 
 
 
 SEM) for IdU, CldU, TUNEL, 
or double-labeled (IdU
 
 
 
/CldU
 
 
 
, IdU
 
 
 
/TUNEL
 
 
 
, or CldU
 
 
 
/TUNEL
 
 
 
) cells 
quantified in the control brain and 8 h after brain irradiation in the SVZ
Staining Brain irradiation Control brain
 
IdU 95.5 
 
 
 
 6.24 161.75 
 
 
 
 1.75
CldU 30 
 
 
 
 3.34 120 
 
 
 
 8.29
TUNEL 416.63 
 
 
 
 9.3 5.13 
 
 
 
 0.71
IdU/CldU
Among IdU
Among CldU
27 
 
 
 
 2.35
(28.56 
 
 
 
 2.97)
 
a
 
(91 
 
 
 
 3)
 
a
 
56.5 
 
 
 
 7.24
(34.85 
 
 
 
 4.17)
 
a
 
(46.82 
 
 
 
 4)
 
a
 
IdU/TUNEL
Among IdU
Among TUNEL
82.25 
 
 
 
 5.28
(88.77   2.77)
a
(19.23   1.5)
a
0.5   0.22
(0.46   0.15)
a
(14.44   8.01)
a
CldU/TUNEL
Among CldU
Among TUNEL
22.5   1.94
(76.66   4.81)
a
(5.55   0.34)
a
0
(0)
a
(0)
a
aParentheses indicate the ratio of double-labeled cells among the total number
of IdU
 , CldU
 , or TUNEL
  cells, as indicated in the left column.BRDU INCORPORATION DURING NEURONAL CELL DEATH IN VIVO • BAUER AND PATTERSON 645
CldU incorporation occurs despite extensive cell death of
the IdU
  cells because 88.8   2.8% are also TUNEL
  after
irradiation, which is in fact slightly more than what is seen
for CldU
  cells (76.7   4.8% are also TUNEL
 ). These re-
sults indicate that CldU does not label a greater proportion
of dying cells even when this nucleoside is administered
during DNA repair/apoptosis. In fact, only 5.6   0.3% of
the TUNEL
  cells are also CldU
 , whereas this value is
much greater for IdU
  cells (19.2   1.5%) and similar to
what is found with the repeated BrdU injections (22.5%),
suggesting that in this experiment most of the BrdU incorpo-
ration is related to cell proliferation.
Altogether, our data indicate that the massive induction
of DNA repair in vivo does not lead to a detectable increased
incorporation of BrdU or related nucleoside. It could be ar-
gued, however, that DNA repair is completed quickly after
brain irradiation and that we may miss this event by injecting
BrdU or CldU 4–6 h after irradiation. We checked for this pos-
sibility in an animal that received an injection of CldU immedi-
ately after brain irradiation, 1 h before perfusion. No difference
in cell death or CldU labeling was detected when compared
with control (unpublished data).
Because TUNEL staining mostly labels cells in late
stages of apoptosis, we also investigated the occurrence of
BrdU incorporation in dying cells at an earlier stage of the ap-
optotic process by staining for casp-3. Although the control
SVZ and SGZ contain only a few casp-3
  cells, brain irradia-
tion induces strong casp-3 staining in both areas (Fig. 4). In-
terestingly, however, very few of the BrdU
  cells in the SVZ
are also casp-3
  (18.8   2.1%) in the repeated injection ex-
periment, which strongly contrasts with our observation for
TUNEL staining ( 73%; Fig. 4 and Table I). This difference
might relate to variable cellular sensitivity to irradiation de-
pending on cell cycle kinetics (Shinomiya, 2001), and one hy-
pothesis is that most casp-3
  cells were not proliferating and
did not incorporate BrdU. This observation may also reflect
the radiosensitizing effect of BrdU (McGinn et al., 1996),
which suggests a general toxicity of BrdU for cells undergoing
DNA repair. BrdU could lead to an induction or accelera-
tion of the cell death process, so that BrdU-containing cells
would quickly resume apoptosis, fragment their DNA, and be
cleared. Interestingly, mature neurons subjected to ischemic
preconditioning can survive in vivo even after expressing high
levels of casp-3 (Tanaka et al., 2004). Our observation there-
fore makes it very unlikely that BrdU would label a casp-3
 
neuron, which could survive and lead to false positive BrdU
staining. Whether a TUNEL
  cell can survive in vivo is cur-
rently unknown.
Kainic acid (KA)–induced seizure
After OBX and brain irradiation, cell death is induced in com-
partments where progenitor cells proliferate, preventing a clear
interpretation of the results. We therefore used the excitotoxic
model of KA-induced seizure, which triggers activation of
DNA repair mechanisms and death of postmitotic hippocampal
pyramidal neurons (Morrison et al., 1996; Djebaili et al., 2001;
Tan et al., 2002). BrdU was either given as a single i.p. injec-
tion (100 mg/kg) 2 h before killing, at 1 or 3 d after KA injec-
tion, or directly infused into the lateral ventricle (Pencea et al.,
2001; Zhao et al., 2003) for a 24-h period before killing, 4 d af-
ter KA injection. The infusion of BrdU was used to maximize
sensitivity because it leads to a much higher uptake into brain
cells than i.p. injection (Pencea et al., 2001).
As previously documented for FVB/N mice (Faherty et
al., 1999), cell death is not detected in the cornu ammonis (CA)
region of the hippocampus 1 d after KA-induced seizure. Only
sparse TUNEL staining is visible in the amygdala, piriform
cortex, and somatosensory cortex (unpublished data). How-
ever, cell death dramatically increases 3–4 d after KA injection
(Figs. 5 and 6). At this time, massive TUNEL staining, exten-
sively colocalizing with NeuN labeling, is found throughout
the CA region of the hippocampus and the somatosensory cor-
tex (layers I–III; Fig. 5), as well as in the piriform and rhinal
cortices, striatum, and amygdala (not depicted). In this context
of neurodegeneration, sparse but numerous BrdU
  nuclei are
detected throughout the brain after a single BrdU injection
(Fig. 6 A). In contrast, infusion of BrdU into the lateral ventri-
cle dramatically increases the density and number of BrdU
 
nuclei in areas surrounding the ventricles (Fig. 6 B).
In spite of numerous examples of close apposition be-
tween BrdU
  and TUNEL
  nuclei, colocalization is not de-
tected in any of the damaged brain areas in animals receiving a
single BrdU injection either 1 or 3 d after KA injection (Fig. 6 A
and Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200505072/DC1). In the BrdU-infused animal, a general
absence of colocalization is similarly seen (Fig. 6 B), despite a
considerably greater number of BrdU
  nuclei and an apparent
progression of cell death in the hippocampus (Fig. 6, A and B;
and Fig. S2). Nevertheless, rare double-stained nuclei are de-
tectable ( 5 colocalizations out of  4,000 TUNEL
  nuclei
per section) exclusively in regions near the lateral ventricle
such as the SVZ, where some of them feature the elongated/bi-
polar shape typical of migrating neurons (Fig. 6, C and D). In
the CA3 area, a total of three BrdU
 /TUNEL
  nuclei are de-
tectable in six sections (Fig. 6 E), whereas no colocalization is
seen in CA1. Most of the double-stained nuclei in the hippo-
campus are present in the stratum radiatum and colocalize with
Figure 5. KA-induced seizure in adult FVB/N
mice leads to massive neuronal cell death.
Postmitotic neurons (NeuN, green) are ex-
tremely TUNEL
  (red) in the CA region of the
hippocampus (A and B) and in the somato-
sensory cortex (C) by 3 d after lesion. Bars:
(A) 200  m; (B) 50  m; (C) 100  m.JCB • VOLUME 171 • NUMBER 4 • 2005 646
the microglia marker Mac-1 (Fig. 6 F). No colocalization be-
tween BrdU, TUNEL, and NeuN is detected (Fig. 6 G). BrdU/
TUNEL colocalization is absent in the somatosensory cortex,
rhinal cortex, and amygdala (unpublished data).
To assess possible activation of DNA repair or cell cycle
mechanisms in injured neurons, we looked at the expression of
p53 and cyclin D1, respectively. In the CA1/CA3 area and the
somatosensory cortex, some postmitotic NeuN
  neurons dis-
play high expression of nuclear p53 protein 3 d after KA injec-
tion (but not at 1 d) but are never positive for BrdU (Fig. 7,
A–D). Surprisingly, we find strong nuclear cyclin D1 immu-
noreactivity in specific populations of postmitotic neurons in
intact control mice (FVB/N and C57BL/6), including CA1 py-
ramidal neurons, where cyclin D1 immunoreactivity abruptly
stops at the junction with CA2/CA3 (Fig. 7, E and F), as well as
in neurons of the piriform cortex (Fig. 7 G) and amygdala (not
depicted). As soon as 1 d after KA injection, cyclin D1 immu-
noreactivity disappears from these structures, probably because
of the progression of cell death, but increases at 3–4 d in corti-
cal reactive astrocytes (Fig. 7 H).
Together, these data demonstrate that BrdU is not signifi-
cantly incorporated in vivo in dying postmitotic neurons after
an excitotoxic lesion. Although some of the dying cells appear
simultaneously positive for BrdU ( 1%), their characteristics
suggest that BrdU was incorporated during proliferation before
cell death rather than during apoptosis/DNA repair.
Discussion
Our examination of three different models of injury-induced
neuronal apoptosis in vivo indicates that BrdU incorporation is
not detected in dying postmitotic neurons. This suggests that
the amount of BrdU that would be incorporated during normal,
ongoing neuronal cell death in vivo is below the detection limit
of immunohistochemistry.
BrdU incorporation in terminally differentiated neurons
undergoing cell death could occur during DNA repair or reen-
try into the cell cycle (Nowakowski and Hayes, 2000; Rakic,
2002a,b). Given the recently demonstrated relationship be-
tween these two mechanisms (Kruman et al., 2004), experi-
mentally identifying the source of BrdU incorporation during
the cell death process is difficult. In a mouse model of KA-
induced excitotoxicity, we find that BrdU is not detected in
dying terminally differentiated neurons (i.e., TUNEL
 ) or in
vulnerable neurons likely undergoing DNA repair (i.e., express-
ing nuclear p53 protein). The absence of cyclin D1 expression,
a regulator of the cell cycle involved in the progression from
G1 to S phase, contrasts with what has been described in the
adult rat brain (Ino and Chiba, 2001) but could be attributable
to the use of different species or antibodies. In addition, we
may have missed an early cyclin D1 induction because it has
been detected in CA3 neurons 12 h after KA injection in CD1
mice (Park et al., 2000). Nevertheless, our results are consistent
with a recently published study using the same model, which
also failed to detect BrdU incorporation in TUNEL
  neurons
after a single BrdU injection (Kuan et al., 2004). Most impor-
tant, we further extend these data by showing that even the di-
rect cerebral infusion of a high dose of BrdU does not result in
the labeling of dying postmitotic neurons, which indicates that
increasing the dose of BrdU does not contribute to nonspecific
staining. Infusion of BrdU was recently used to detect low lev-
els of neurogenesis in the substantia nigra (Zhao et al., 2003;
Frielingsdorf et al., 2004), whereas neurogenesis was not de-
tected using an i.p. injection (Lie et al., 2002).
Could BrdU incorporation in injured 
terminally differentiated neurons in vitro 
be an artifact?
Recent studies (Greene et al., 2004) indicate that BrdU incor-
poration in postmitotic neurons is primarily found in cultured
embryonic cortical neurons (Copani et al., 1999; Wu et al.,
2000; McPhie et al., 2003; Kruman et al., 2004) or early post-
natal cerebellar granule cells (Verdaguer et al., 2002) that are
injured by various means. In contrast, BrdU incorporation in
vulnerable or dying neurons in vivo has rarely been directly
demonstrated after injury or during physiological programmed
cell death, although activation of cell cycle–related proteins is
commonly observed (Greene et al., 2004). Only indirect obser-
Figure 6. BrdU and TUNEL staining 3–4 d
after KA injection shows a major increase in
neuronal death but rare double labeling. (A
and B) BrdU was either injected i.p. (100
mg/kg) 2 h before killing (Inj) or directly in-
fused in the lateral ventricle for 24 h (Inf).
Massive cell death is detected in both the hip-
pocampus (A, B, and CA1) and the soma-
tosensory cortex (CX). (A) However, BrdU/
TUNEL colocalization is absent in animals re-
ceiving a single BrdU injection. (B) Similarly,
after infusion of BrdU, which leads to a much
higher uptake of the marker into brain cells,
the majority of dying cells is not positive for
BrdU. Rare colocalization is nonetheless de-
tectable in this case, specifically in areas close
to the lateral ventricle, such as the SVZ (C) or the corpus callosum (D). A total of three BrdU
 /TUNEL
  nuclei are detected in the CA3 area in six sections
containing  24,000 TUNEL
  nuclei (E, arrow and insets). In the hippocampal formation, most of the double-stained nuclei are found in the stratum radia-
tum and colocalize with Mac-1, a marker of microglia (blue in F, arrow and insets) but not with NeuN (blue in G, arrow). Vertical images represent
orthogonal projections along the z axis. Insets in E and F are 18 and 34  m wide, respectively. BrdU is in green, and TUNEL is in red. Bars: (A and B)
200  m; (C and D) 10  m; (E) 30  m; (CA1, CX, F, and G) 50  m.BRDU INCORPORATION DURING NEURONAL CELL DEATH IN VIVO • BAUER AND PATTERSON 647
vations such as a spatial correlation between proliferating and
dying neurons or the pycnotic aspect of a BrdU
  nucleus were
suggestive of BrdU incorporation in dying or committed-to-
death postmitotic neurons (Lee et al., 1992; Herrup and Busser,
1995; Klein et al., 2002; El-Khodor et al., 2003). Menu dit
Huart et al. (2004) indicated BrdU/TUNEL double staining by
“data not shown.” Moreover, such in vivo observations were
exclusively made during embryonic development or early post-
natal life (except by Klein et al., 2002). In the adult brain, only
a few studies have directly evaluated possible BrdU incor-
poration in dying postmitotic neurons after injury, including
adrenalectomy, traumatic brain injury, hypoxia, ischemia, and
KA-induced excitotoxicity (Katchanov et al., 2001; Tonchev et
al., 2003a,b; Kuan et al., 2004). Interestingly, although each of
these insults produced virtually no BrdU labeling in dying neu-
rons when performed separately, the combination of ischemia
and hypoxia was recently reported to induce terminally differ-
entiated neurons to reenter the cell cycle and incorporate BrdU
(Kuan et al., 2004). This suggests that the DNA damage re-
sponse induced by a single insult, such as ischemia or excito-
toxicity, may not be sufficient to trigger cell cycle reentry of
terminally differentiated neurons, whereas a combination of
insults (ischemia plus hypoxia) could synergistically activate
specific components of the DNA damage response that trigger
aberrant cell cycle reactivation in postmitotic neurons in vivo.
Additionally, experimental models that induce neuronal cell
death may not be efficient in inducing cell cycle reactivation of
postmitotic neurons, which could also rely on different suscep-
tibility to DNA damage among various neuronal populations
(Pieper et al., 2000). Nevertheless, in the normal adult brain, or
when dealing with classical injury models of acute neuronal
cell death, BrdU appears to be a specific and reliable marker
for studying neurogenesis, even when a high dose of BrdU is
directly infused into the brain.
Reactivation of the cell cycle and BrdU 
incorporation in neurodegenerative 
disease
In neurodegenerative disorders such as AD or amytrophic lat-
eral sclerosis, at-risk neurons express cell cycle–related pro-
teins such as proliferating cell nuclear antigen, cyclin D1,
Cdk4, pRb, cyclin B, or cdc2 (Greene et al., 2004). Surpris-
ingly, however, many of these proteins are cytoplasmically lo-
calized (Bowser and Smith, 2002). Furthermore, proliferating
cell nuclear antigen, which is considered as a marker for cy-
cling cells, is also involved in DNA repair (Uberti et al., 2003)
and can be expressed in postmitotic neurons (Ino and Chiba,
2000). We find that cyclin D1 is specifically expressed at rel-
atively high levels in some neuronal populations of the con-
trol mouse brain, where it is localized in the nucleus, as is
seen in cycling cells. This result was unexpected because
these neuronal populations are clearly noncycling and postmi-
totic, and it suggests that cyclin D1 might have a role distinct
from its classic regulation of the progression into the cell cy-
cle. That is, the up-regulation of cell cycle–related proteins
seen in neurodegenerative disorders is not directly conclusive
of cell cycle reactivation.
Recently, Yang et al. (2001) used FISH to show that some
vulnerable neurons in human brains with AD are aneuploid,
which was interpreted as evidence of DNA replication preced-
ing neuronal cell death. However, the FISH technique gives an
indication of the amount of nuclear DNA, haploid to tetraploid
depending on the number of hybridization spots (Yang et al.,
2001), and does not indicate recent or abnormal replication or
proliferation. Other mechanisms that could explain the presence
of aneuploid cells in brains with AD, such as cell fusion (Alva-
rez-Dolado et al., 2003), should be considered. Most important,
recent studies in the normal mouse have shown that embryonic
and postnatal neural progenitor cells, as well as 5–7% of the
neurons in the adult brain, are aneuploid (Kaushal et al., 2003;
McConnell et al., 2004). Constitutive aneuploidy has also been
recently reported in the normal adult human brain (Rehen et al.,
2005). The study by Yang et al. (2001), however, did not find
such abnormalities in age-matched control brains, suggesting
that aneuploidy might be increased in AD. According to this hy-
pothesis, AD would be characterized by the failed elimination
of aneuploid neurons, which could even accumulate slowly
with age during adult neurogenesis (Eriksson et al., 1998; Jin
et al., 2004) and lead to functional disturbances of the brain. In
this context, it is interesting to note that mice lacking ataxia-
Figure 7. Markers of DNA repair (p53 protein) and cell cycle (cyclin D1)
do not label BrdU
  cells. After KA injection, a few NeuN
  postmitotic neu-
rons (blue) express a high level of nuclear p53 protein (A–D, red) but are
never positive for BrdU (green), either in the CA1/CA3 areas (A and B) or
the cortex (C and D). Surprisingly, the intact adult mouse brain (E–G) con-
tains populations of postmitotic neurons (NeuN
 , green) showing a high
level of nuclear cyclin D1 (E–H, red) immunoreactivity, including pyrami-
dal neurons of the CA1 area (E and F), where cyclin D1 immunoreactivity
abruptly stops at the junction with CA2/CA3 (E and F, arrows), and neu-
rons of the piriform cortex (G). After KA injection, cyclin D1 is highly ex-
pressed in hypertrophic reactive glial fibrillary acidic protein (GFAP
 ) as-
trocytes (green) in the cortex (H). Bars: (A–D and G) 50  m; (E and F)
500  m; (H) 30  m.JCB • VOLUME 171 • NUMBER 4 • 2005 648
telangiectasia, a protein involved in the control of DNA repair,
cell cycle, and apoptosis (Shiloh, 2003), fail to eliminate aneu-
ploid neurons (McConnell et al., 2004) and display age-depen-
dent neurodegeneration in the substantia nigra and striatum
(Eilam et al., 2003). Moreover, recent analyses of a mouse
model of AD characterized by neuronal loss (APP23 [amyloid
precursor protein transgenic mice]; Calhoun et al., 1998) have
shown that cortical neurons do not incorporate BrdU or express
markers of the cell cycle, whereas astrocytes do (Bondolfi et al.,
2002; Gartner et al., 2003).
Injury-induced neuronal death could occur through path-
ways that are distinct from naturally occurring cell death, espe-
cially during slow, progressive neurodegenerative disorders
such as AD. Interestingly, a recent study of the normal devel-
opment of the rabbit cerebellum suggests that apoptosis of
granule cells is controlled by two distinct mechanisms, one in-
volving the activation of cell cycle proteins in premigratory
neurons and the other being the more classic caspase-dependent
pathway in postmigratory neurons, without reactivation of the
cell cycle (Lossi et al., 2004). This observation could explain
why many in vitro studies, which use embryonic or neonatal
neurons, as well as in vivo studies using perinatal animals, re-
port BrdU incorporation in dying neurons. Within the adult
brain, neurons may behave differently, and despite an up-regu-
lation of cell cycle–related proteins, our results as well as those
of others (Katchanov et al., 2001; Tonchev et al., 2003a,b)
demonstrate that dying postmitotic neurons rarely progress
through S phase or incorporate BrdU.
Materials and methods
Animals
2- to 4-mo-old C57BL/6 mice (The Jackson Laboratory) were subjected to
unilateral OBX (Bauer et al., 2003) or brain irradiation with a Cesium
137
source calibrated to deliver 20 grays in 25 min (Mark I-68A; J.L. Shep-
herd & Assoc.). FVB/N mice received a subcutaneous injection of 30 mg/
kg KA (Sigma-Aldrich) dissolved in saline and were carefully monitored
for seizure activity. Mice undergoing status epilepticus for at least 4 h
were analyzed. Seizures were stopped by an i.p. injection of 10 mg/kg
diazepam (Steris Laboratories) as needed.
Treatments with thymidine analogues
BrdU and CldU (Sigma-Aldrich) were dissolved in 16.67 mg/ml saline
and IdU (Sigma-Aldrich) in 10 mg/ml PBS/NaOH, pH  8.0. Solutions
were sterile filtered and injected i.p. or delivered by intracerebroventricu-
lar infusion with a minipump (1  l/h; model 1003D; Alzet) attached to a
Brain infusion kit II (Alzet), with the cannula implanted in the right lateral
ventricle (lateral, 0.8 mm; anterior,  0.1 mm to the bregma; depth, 3 mm
from skull surface). The pump was left in place for 24 h, delivering a total
of 0.4 mg BrdU.
Double staining for BrdU and TUNEL
For BrdU/TUNEL double staining, TUNEL labeling was performed first, as
described previously (Bauer et al., 2003), and revealed with streptavidin
Alexa 568 (Invitrogen). Sections were fixed for 30 min at RT in 4% PFA in
0.1 M phosphate buffer, pH 7.4, and rinsed with PBS. BrdU staining was
done using the HCl method as described previously (Bauer et al., 2005)
and revealed with Alexa 488 goat anti–rat (Invitrogen). Additional stain-
ing was performed either before the TUNEL reaction or after BrdU staining
and revealed with Alexa 633–conjugated secondary antibodies.
Double staining for IdU and CldU
Anti-BrdU antibodies cross-reacting with CldU (Immunologicals.com) or IdU
(BD Biosciences) were incubated overnight at RT in PBS containing 10% nor-
mal goat serum, 5% BSA, and 0.1% Triton X-100 (CldU first, followed by
IdU; Maslov et al., 2004). Possible cross-reactivity was removed by wash-
ing 6   10 min with a high-stringency solution (40 mM Tris-HCl, 50 mM
NaCl, and Tween 1%, pH 8.0). Specificity was checked using brain sec-
tions from animals injected with IdU or CldU and stained for CldU or IdU,
respectively, which gave no detectable staining. This control procedure was
repeated systematically when we performed the double staining. We also
compared the sensitivity of IdU, CldU, and BrdU incorporation/detection by
quantifying cells labeled in the SVZ of animals injected with 100 mg/kg of
either thymidine analogue 2 h before perfusion. The number of IdU- or
CldU-labeled cells was within 5–7% of the number of BrdU
  cells, whereas
only a 1% difference was seen between IdU
  and CldU
  cells.
Triple-staining immunohistochemistry
Primary antibodies used include mouse anti-TuJ1 (Covance), mouse anti-
Ki67 (BD Biosciences), mouse anti-NeuN (Chemicon), rat anti–Mac-1 (Bio-
source International), rat anti–glial fibrillary acidic protein (Zymed Labora-
tories), rabbit anti-p53 (Novocastra), rabbit monoclonal anti–cyclin D1 (a
gift from C. Pagtakhan, Lab Vision, Fremont, CA), and rabbit anti–casp-3
(Cell Signaling Technology). Antibodies were incubated overnight at 4 C
or RT in PBS containing 0.1% Triton X-100 and 10% normal goat serum.
Species-specific secondary antibodies conjugated to Alexa 488, 568, or
633 were purchased from Invitrogen. Nonspecific staining was systemati-
cally checked by omission of the primary antibody. For p53 staining, sec-
tions were first incubated for 10 min in boiling 0.01 M citrate buffer, pH
6.0. For cyclin D1 staining, additional control consisted of preincubating
the antibody with the synthetic peptide antigen (Lab Vision) for 1 h at RT,
resulting in the disappearance of the staining in a concentration-depen-
dent manner. In addition, a mouse monoclonal anti–cyclin D1 (Santa Cruz
Biotechnology, Inc.) gave similar staining in the hippocampus, although
much weaker and with less contrast.
Confocal microscopy and quantification
Double or triple staining was analyzed in three dimensions with an LSM
410/Axiovert 135 system (Carl Zeiss MicroImaging, Inc.) equipped with
three laser lines (488, 568, and 633 nm). Confocal photomicrographs
were acquired with the LSM software version 3.993 (Carl Zeiss MicroIm-
aging, Inc.) at a size of 512   512 or 768   576 pixels by averaging
8–16 scans. Each channel was acquired separately using specific laser
lines to avoid bleed through of the fluorochromes. Objectives used had a
magnification of 10  (NA 0.3), 20  (NA 0.75), or 63  (oil immersion,
NA 1.25). In Figs. 5 and 6, confocal photomicrographs were acquired at
10 , and the hippocampal formation was reconstructed by assembling
two to three pictures in Photoshop version 7.0.1 (Adobe Systems, Inc.).
Nonconfocal photomicrographs were acquired with a Spot RT Slider
charge-coupled device camera controlled by the Spot software version
3.4 (Diagnostic Instruments) and attached to a microscope (Diaphot 300;
Nikon). For all stainings, Photoshop version 7.0.1 was used to adjust con-
trast and brightness so that individual pictures on the same composite fig-
ure appeared similar. Nuclei showing clear colocalizations between thy-
midine analogues and TUNEL staining were quantified and recorded at
the confocal microscope. Quantification was also performed on the micro-
scope using a 63  objective (oil immersion, NA 1.4). At least six sections
per animal per condition were analyzed for qualitative purposes, and at
least two sections were used for quantification.
Online supplemental material
Figs. S1 and S2 show the extent of cell death and BrdU incorporation in
the cortex and hippocampus, respectively, after KA-induced seizures.
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200505072/DC1.
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